ATR and glioblastoma: To note, given the well-characterized immunosuppressive tumor microenvironment associated with GBM, ATR treatment may present two weapons against this disease: targeting the addiction to the DDR pathway and reinvigorating T cells to attack GBM cells following radiotherapy (87, 95).